Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 1.99 Delayed Data As of May 27 |  +0.235 / +13.43%Today’s Change | 1.60 Today|||52-Week Range 10.33 | -60.22% Year-to-Date |
Latest INO News | Press Releases
No recent news for Inovio Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.75 |
| Today’s open | 1.84 |
| Day’s range | 1.79 - 2.00 |
| Volume | 535,772 |
| Average volume (3 months) | 5,409,222 |
| Market cap | $427.2M |
Data as of 4:00pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -35.56% |
| Earnings growth (this year) | +19.66% |
| Earnings growth (next 5 years) | +22.71% |
| Revenue growth (last year) | -76.05% |
| P/E ratio | NM |
| Price/Sales | 587.16 |
| Price/Book | 1.01 |
Competitors
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $1.8M |
| Annual profit (last year) | -$303.7M |
| Net profit margin | -17,109.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
